Position in AMGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,187,746,295
+$164,427,822 QoQ
Shares Held
6,217,838
+0.6% QoQ
Ownership
1.15%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 96.46820968960593.ToString("F0")%
Shared 3.4637923985796992.ToString("F0")%
None 0.06799791181436377.ToString("F0")%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $32,017,375,581 across 17 Drug Manufacturers - General names. AMGN ranks #5 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,827,564 | $8,119,328,534 | |
| 2 | JNJ |
Johnson & Johnson
|
29,319,669 | $7,166,899,886 | |
| 3 | ABBV |
AbbVie Inc.
|
21,211,382 | $4,613,263,466 | |
| 4 | MRK |
Merck & Co., Inc.
|
27,090,023 | $3,258,658,860 | |
| 5 | AMGN |
Amgen Inc
This page
|
6,217,838 | $2,187,746,295 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
13,820,379 | $1,926,146,218 | |
| 7 | PFE |
Pfizer Inc
|
62,026,552 | $1,741,705,574 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
24,758,771 | $1,501,619,457 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,187,746,295 | 6,217,838 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $2,023,318,473 | 6,181,658 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,733,972,253 | 6,144,480 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,714,843,317 | 6,141,769 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,933,500,167 | 6,206,067 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,676,183,394 | 6,431,029 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,790,126,260 | 5,555,775 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $1,828,701,734 | 5,852,782 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $1,710,649,378 | 6,016,634 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,847,078,594 | 6,413,022 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,875,306,493 | 6,977,625 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,492,454,405 | 6,722,162 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,680,205,288 | 6,950,177 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,866,786,287 | 7,107,776 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,614,230,724 | 7,161,627 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,773,001,791 | 7,287,307 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,845,503,254 | 7,631,723 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $1,726,899,637 | 7,676,133 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,665,611,105 | 7,832,641 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,847,382,223 | 7,579,004 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,927,728,373 | 7,747,793 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $1,821,096,303 | 7,920,565 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $2,068,400,080 | 8,138,181 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,881,787,780 | 7,978,410 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $1,618,432,511 | 7,983,192 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||